Sphingosine kinase and sphingosine-1-phosphate receptors: Novel therapeutic targets of rheumatoid arthritis?

Future Medicinal Chemistry

Volumn 4, Issue 6, 2012, Pages 727-733

  Lai, Wen Qi ^a   Chia, Faith Li Ann ^b   Leung, Bernard P ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; CYTOKINE; FINGOLIMOD; GELATINASE B; SMALL INTERFERING RNA; SPHINGOLIPID; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE KINASE;

AUTOIMMUNE DISEASE; B LYMPHOCYTE; BIOLOGY; CELL MATURATION; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG TARGETING; ENZYME ACTIVITY; FIBROBLAST; HUMAN; IMMUNOMODULATION; MULTIPLE SCLEROSIS; NONHUMAN; OSTEOARTHRITIS; OSTEOCLAST; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYNOVIAL FLUID; SYNOVITIS; TH17 CELL;

ANIMALS; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CYTOKINES; HUMANS; MOLECULAR TARGETED THERAPY; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RECEPTORS, LYSOSPHINGOLIPID;

EID: 84860254644     PISSN: 17568919     EISSN: 17568927     Source Type: Journal    
DOI: 10.4155/fmc.12.28     Document Type: Review

References (63)

1. Oliver JE, Silman AJ. Risk factors for the development of rheumatoid arthritis. Scand. J. Rheumatol. 35(3), 169-174 (2006).
2. Brennan FM, Mcinnes IB. Evidence that cytokines play a role in rheumatoid arthritis. J. Clin. Invest. 118(11), 3537-3545 (2008).
3. McInnes IB, O'Dell JR. State-of-The-Art: Rheumatoid arthritis. Ann. Rheum. Dis. 69(11), 1898-1906 (2010).
4. Sweeney SE, Firestein GS. Primer: Signal transduction in rheumatic disease - A clinician's guide. Nat. Clin. Pract. Rheumatol. 3(11), 651-660 (2007).
5. Bartke N, Hannun YA. Bioactive sphingolipids: Metabolism and function. J. Lipid Res. 50(Suppl.), S91-96 (2009).
6. Hait NC, Oskeritzian CA, Paugh SW, Milstien S, Spiegel S. Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases. Biochim. Biophys. Acta 1758(12), 2016-2026 (2006).
7. Hait NC, Allegood J, Maceyka M et al. Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. Science 325(5945), 1254-1257 (2009).
8. Spiegel S, Milstien S. Sphingosine 1-phosphate, a key cell signaling molecule. J. Biol. Chem. 277(29), 25851-25854 (2002).
9. Strub GM, Maceyka M, Hait NC, Milstien S, Spiegel S. Extracellular and intracellular actions of sphingosine-1-phosphate. Adv. Exp. Med. Biol. 688, 141-155 (2010).
10. Van Brocklyn JR, Behbahani B, Lee NH. Homodimerization and heterodimerization of S1P/EDG sphingosine-1-phosphate receptors. Biochim. Biophys. Acta 1582(1-3), 89-93 (2002).
11. Lee MJ, Thangada S, Claffey KP et al. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell 99(3), 301-312 (1999).
12. Lee MJ, Van Brocklyn JR, Thangada S et al. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science 279(5356), 1552-1555 (1998).
13. Zhang Q, Peyruchaud O, French KJ, Magnusson MK, Mosher DF. Sphingosine 1-phosphate stimulates fibronectin matrix assembly through a Rho-dependent signal pathway. Blood 93(9), 2984-2990 (1999).
14. Sanchez T, Hla T. Structural and functional characteristics of S1P receptors. J. Cell. Biochem. 92(5), 913-922 (2004).
15. Mackinnon AC, Buckley A, Chilvers ER, Rossi AG, Haslett C, Sethi T. Sphingosine kinase: A point of convergence in the action of diverse neutrophil priming agents. J. Immunol. 169(11), 6394-6400 (2002).
16. Olivera A, Urtz N, Mizugishi K et al. IgE-dependent activation of sphingosine kinases 1 and 2 and secretion of sphingosine 1-phosphate requires Fyn kinase and contributes to mast cell responses. J. Biol. Chem. 281(5), 2515-2525 (2006).
17. Nincheri P, Bernacchioni C, Cencetti F, Donati C, Bruni P. Sphingosine kinase-1/S1P1 signalling axis negatively regulates mitogenic response elicited by PDGF in mouse myoblasts. Cell Signal. 22(11), 1688-1699 (2010).
18. Hobson JP, Rosenfeldt HM, Barak LS et al. Role of the sphingosine-1-phosphate receptor EDG-1 in PDGF-induced cell motility. Science 291(5509), 1800-1803 (2001).
19. Aktas O, Kury P, Kieseier B, Hartung HP. Fingolimod is a potential novel therapy for multiple sclerosis. Nat. Rev. Neurol. 6(7), 373-382 (2010).
20. Hla T, Brinkmann V. Sphingosine 1-phosphate (S1P): Physiology and the effects of S1P receptor modulation. Neurology 76(8 Suppl 3), S3-8 (2011).
21. Maceyka M, Sankala H, Hait NC et al. SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism. J. Biol. Chem. 280(44), 37118-37129 (2005).
22. Matloubian M, Lo CG, Cinamon G et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427(6972), 355-360 (2004).
23. Allende ML, Dreier JL, Mandala S, Proia RL. Expression of the sphingosine 1-phosphate receptor, S1P1, on T-cells controls thymic emigration. J. Biol. Chem. 279(15), 15396-15401 (2004).
24. Piali L, Froidevaux S, Hess P et al. The selective sphingosine 1-phosphate receptor 1 agonist ponesimod protects against lymphocyte-mediated tissue inflammation. J. Pharmacol. Exp. Ther. 337(2), 547-556 (2011).
25. Lai WQ, Irwan AW, Goh HH et al. Anti-inflammatory effects of sphingosine kinase modulation in inflammatory arthritis. J. Immunol. 181(11), 8010-8017 (2008).
26. Dayer JM, Burger D. Cell-cell interactions and tissue damage in rheumatoid arthritis. Autoimmun. Rev. 3(Suppl. 1), S14-S16 (2004).
27. 4+ effector memory T cells are precursors of bystander-Activated effectors: A surrogate model of rheumatoid arthritis synovial T-cell function. Arthritis Res. Ther. 10(2), R36 (2008).
28. Mcinnes IB, Leung BP, Sturrock RD, Field M, Liew FY. Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-Alpha production in rheumatoid arthritis. Nat. Med. 3(2), 189-195 (1997).
29. Jovanovic DV, Martel-Pelletier J, Di Battista JA et al. Stimulation of 92-kd gelatinase MMP-9 production IL-17 in human monocyte/macrophages: A possible role in rheumatoid arthritis. Arthritis Rheum. 43(5), 1134-1144 (2000).
30. Kim HL, Sacket SJ, Han M, Im DS. Characterization of N,N,-dimethyl-d- erythro-sphingosine-induced apoptosis and signaling in U937 cells: Independence of sphingosine kinase inhibition. Prostaglandins Other Lipid Mediat. 86(1-4), 18-25 (2008).
31. Bartok B, Firestein GS. Fibroblast-like synoviocytes: Key effector cells in rheumatoid arthritis. Immunol. Rev. 233(1), 233-255 (2010).
32. McInnes IB, Leung BP, Liew FY. Cell-cell interactions in synovitis. Interactions between T lymphocytes and synovial cells. Arthritis Res. 2(5), 374-378 (2000).
33. Zhao C, Fernandes MJ, Turgeon M et al. Specific and overlapping sphingosine-1-phosphate receptor functions in human synoviocytes: Impact of TNF-Alpha. J. Lipid Res. 49(11), 2323-2337 (2008).
34. Pi X, Tan SY, Hayes M et al. Sphingosine kinase 1-mediated inhibition of Fas death signaling in rheumatoid arthritis B lymphoblastoid cells. Arthritis Rheum. 54(3), 754-764 (2006).
35. Kitano M, Hla T, Sekiguchi M et al. Sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 signaling in rheumatoid synovium: Regulation of synovial proliferation and inflammatory gene expression. Arthritis Rheum. 54(3), 742-753 (2006).
36. Kamada K, Arita N, Tsubaki T et al. Expression of sphingosine kinase 2 in synovial fibroblasts of rheumatoid arthritis contributing to apoptosis by a sphingosine analogue, FTY720. Pathol. Int. 59(6), 382-389 (2009).
37. Baker DA, Obeid LM, Gilkeson GS. Impact of sphingosine kinase on inflammatory pathways in fibroblast-like synoviocytes. Inflamm. Allergy Drug Targets. 10(6), 464-471 (2011).
38. Cohen SB, Keystone E, Genovese MC et al. Continued inhibition of structural damage over 2 years in patients with rheumatoid arthritis treated with rituximab in combination with methotrexate. Ann. Rheum. Dis. 69(6), 1158-1161 (2010).
39. Steiner G, Smolen J. Autoantibodies in rheumatoid arthritis and their clinical significance. Arthritis Res. 4(Suppl. 2), S1-S5 (2002).
40. Raptopoulou A, Sidiropoulos P, Katsouraki M, Boumpas DT. Anti-citrulline antibodies in the diagnosis and prognosis of rheumatoid arthritis: Evolving concepts. Crit. Rev. Clin. Lab. Sci. 44(4), 339-363 (2007).
41. Takemura S, Klimiuk PA, Braun A, Goronzy JJ, Weyand CM. T cell activation in rheumatoid synovium is B cell dependent. J. Immunol. 167(8), 4710-4718 (2001).
42. Buch MH, Boyle DL, Rosengren S et al. Mode of action of abatacept in rheumatoid arthritis patients having failed tumour necrosis factor blockade: A histological, gene expression and dynamic magnetic resonance imaging pilot study. Ann. Rheum. Dis. 68(7), 1220-1227 (2009).
43. Tan SY, Xiao L, Pi X, Holoshitz J. Aberrant Gi protein coupled receptor-mediated cell survival signaling in rheumatoid arthritis B cell lines. Front. Biosci. 12, 1651-1660 (2007).
44. Lai WQ, Irwan AW, Goh HH, Melendez AJ, Mcinnes IB, Leung BP. Distinct roles of sphingosine kinase 1 and 2 in murine collagen-induced arthritis. J. Immunol. 183(3), 2097-2103 (2009).
45. Kabashima K, Haynes NM, Xu Y et al. Plasma cell S1P1 expression determines secondary lymphoid organ retention versus bone marrow tropism. J. Exp. Med. 203(12), 2683-2690 (2006).
46. Allende ML, Tuymetova G, Lee BG, Bonifacino E, Wu YP, Proia RL. S1P1 receptor directs the release of immature B cells from bone marrow into blood. J. Exp. Med. 207(5), 1113-1124 (2010).
47. Arnon TI, Xu Y, Lo C et al. GRK2-dependent S1PR1 desensitization is required for lymphocytes to overcome their attraction to blood. Science 333(6051), 1898-1903 (2011).
48. Ryu J, Kim HJ, Chang EJ, Huang H, Banno Y, Kim HH. Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast coupling. EMBO J. 25(24), 5840-5851 (2006).
49. Ishii M, Egen JG, Klauschen F et al. Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis. Nature 458(7237), 524-528 (2009).
50. Ishii M, Kikuta J, Shimazu Y, Meier-Schellersheim M, Germain RN. Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo. J. Exp. Med. 207(13), 2793-2798 (2010).
51. Iwakura Y, Ishigame H, Saijo S, Nakae S. Functional specialization of interleukin-17 family members. Immunity 34(2), 149-162 (2011).
52. Awasthi A, Murugaiyan G, Kuchroo VK. Interplay between effector Th17 and regulatory T cells. J. Clin. Immunol. 28(6), 660-670 (2008).
53. Mangan PR, Harrington LE, O'Quinn DB et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441(7090), 231-234 (2006).
54. Veldhoen M, Stockinger B. TGFbeta1, a 'Jack of all trades': The link with pro-inflammatory IL-17-producing T cells. Trends Immunol. 27(8), 358-361 (2006).
55. McKenzie BS, Kastelein RA, Cua DJ. Understanding the IL-23-IL-17 immune pathway. Trends Immunol. 27(1), 17-23 (2006).
56. Wilson NJ, Boniface K, Chan JR et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol. 8(9), 950-957 (2007).
57. Huang MC, Watson SR, Liao JJ, Goetzl EJ. Th17 augmentation in OTII TCR plus T cell-selective type 1 sphingosine 1-phosphate receptor double transgenic mice. J. Immunol. 178(11), 6806-6813 (2007).
58. Liao JJ, Huang MC, Goetzl EJ. Cutting edge: Alternative signaling of Th17 cell development by sphingosine 1-phosphate. J. Immunol. 178(9), 5425-5428 (2007).
59. Kollias G, Papadaki P, Apparailly F et al. Animal models for arthritis: Innovative tools for prevention and treatment. Ann. Rheum. Dis. 70(8), 1357-1362 (2011).
60. Baker DA, Barth J, Chang R, Obeid LM, Gilkeson GS. Genetic sphingosine kinase 1 deficiency significantly decreases synovial inflammation and joint erosions in murine TNF-Alpha-induced arthritis. J. Immunol. 185(4), 2570-2579 (2010).
61. Michaud J, Kohno M, Proia RL, Hla T. Normal acute and chronic inflammatory responses in sphingosine kinase 1 knockout mice. FEBS Lett. 580(19), 4607-4612 (2006).
62. Mizugishi K, Yamashita T, Olivera A, Miller GF, Spiegel S, Proia RL. Essential role for sphingosine kinases in neural and vascular development. Mol. Cell. Biol. 25(24), 11113-11121 (2005).
63. Samy ET, Meyer CA, Caplazi P et al. Cutting edge: Modulation of intestinal autoimmunity and IL-2 signaling by sphingosine kinase 2 independent of sphingosine 1-phosphate. J. Immunol. 179(9), 5644-5648 (2007).